Virtu Financial’s Loxo Oncology, Inc LOXO Stock Holding History

Virtu Financial’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,109	Closed	-$851K	–	2998
2017 Q4	$851K	Buy	10,109 +4,630	+85%	+$386K	0.05%	514
2017 Q3	$505K	Buy	+5,479	New	+$426K	0.03%	929

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Virtu Financial's LOXO Position: Q1 2018 in Review

Virtu Financial sold out of Loxo Oncology, Inc (LOXO) in Q1 2018, closing a stake of 10,109 shares — an estimated $851K sold.

Virtu Financial first reported a position in LOXO in Q3 2017 and held it in 2 quarters. The position peaked at $851K in Q4 2017. 158 funds tracked by Wall St. Rank hold LOXO as of Q1 2018.

Virtu Financial reported no remaining Loxo Oncology, Inc position as of Q1 2018 after selling out during the quarter.
Virtu Financial sold 10,109 Loxo Oncology, Inc shares in Q1 2018, an estimated $851K.
Virtu Financial first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 2 quarters.
Virtu Financial's Loxo Oncology, Inc position peaked at $851K in Q4 2017.
158 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.